RXQ Compounding LLC Recall: FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50M
RXQ Compounding LLC Recall: FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50M is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: RXQ Compounding LLC; Product: FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State St
| Recalling firm | RXQ Compounding LLC |
|---|---|
| Product | FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide USA |
| Recall initiated | 20190619 |
| Recall number | D-1659-2019 |
| Category | drug |
| State | OH |
| Country | United States |
$29/mo
Try RecallGuard →